{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["GATA binding protein 2", "GATA binding protein\u00a01", "LIM Domain Binding 1", "erythroblast transformation\u2011specific\u2011related gene", "erythroid differentiation/megakaryocytic differentiation", "friend leukemia integration factor\u00a01", "transcriptional regulation"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38695236", "DateCompleted": {"Year": "2024", "Month": "05", "Day": "02"}, "DateRevised": {"Year": "2024", "Month": "05", "Day": "20"}, "Article": {"Language": ["eng"], "ELocationID": ["107", "10.3892/mmr.2024.13231"], "ArticleDate": [{"Year": "2024", "Month": "05", "Day": "02"}], "Journal": {"ISSN": "1791-3004", "JournalIssue": {"Volume": "29", "Issue": "6", "PubDate": {"Year": "2024", "Month": "Jun"}}, "Title": "Molecular medicine reports", "ISOAbbreviation": "Mol Med Rep"}, "ArticleTitle": "An intricate regulatory circuit between FLI1 and GATA1/GATA2/LDB1/ERG dictates erythroid vs. megakaryocytic differentiation.", "Abstract": {"AbstractText": ["During hematopoiesis, megakaryocytic erythroid progenitors (MEPs) differentiate into megakaryocytic or erythroid lineages in response to specific transcriptional factors, yet the regulatory mechanism remains to be elucidated. Using the MEP\u2011like cell line HEL western blotting, RT\u2011qPCR, lentivirus\u2011mediated downregulation, flow cytometry as well as chromatin immunoprecipitation (ChIp) assay demonstrated that the E26 transformation\u2011specific (ETS) transcription factor friend leukemia integration factor 1 (Fli\u20111) inhibits erythroid differentiation. The present study using these methods showed that while FLI1\u2011mediated downregulation of GATA binding protein 1 (GATA1) suppresses erythropoiesis, its direct transcriptional induction of GATA2 promotes megakaryocytic differentiation. GATA1 is also involved in megakaryocytic differentiation through regulation of GATA2. By contrast to FLI1, the ETS member erythroblast transformation\u2011specific\u2011related gene (<i>ERG</i>) negatively controls GATA2 and its overexpression through exogenous transfection blocks megakaryocytic differentiation. In addition, FLI1 regulates expression of LIM Domain Binding 1 (LDB1) during erythroid and megakaryocytic commitment, whereas shRNA\u2011mediated depletion of LDB1 downregulates FLI1 and GATA2 but increases GATA1 expression. In agreement, LDB1 ablation using shRNA lentivirus expression blocks megakaryocytic differentiation and modestly suppresses erythroid maturation. These results suggested that a certain threshold level of LDB1 expression enables FLI1 to block erythroid differentiation. Overall, FLI1 controlled the commitment of MEP to either erythroid or megakaryocytic lineage through an intricate regulation of GATA1/GATA2, LDB1 and ERG, exposing multiple targets for cell fate commitment and therapeutic intervention."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou 550014, P.R. China."}], "LastName": "Wang", "ForeName": "Chunlin", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou 550014, P.R. China."}], "LastName": "Hu", "ForeName": "Maoting", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou 550014, P.R. China."}], "LastName": "Yu", "ForeName": "Kunlin", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou 550014, P.R. China."}], "LastName": "Liu", "ForeName": "Wuling", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou 550014, P.R. China."}], "LastName": "Hu", "ForeName": "Anling", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou 550014, P.R. China."}], "LastName": "Kuang", "ForeName": "Yi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou 550014, P.R. China."}], "LastName": "Huang", "ForeName": "Lei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou 550014, P.R. China."}], "LastName": "Gajendran", "ForeName": "Babu", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicine, University of Toronto, Toronto, Ontario M5S3H2, Canada."}], "LastName": "Zacksenhaus", "ForeName": "Eldad", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou 550014, P.R. China."}], "LastName": "Xiao", "ForeName": "Xiao", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, Guizhou 550014, P.R. China."}], "LastName": "Ben-David", "ForeName": "Yaacov", "Initials": "Y"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Mol Med Rep", "NlmUniqueID": "101475259", "ISSNLinking": "1791-2997"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "ERG protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "FLI1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "GATA1 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "GATA2 protein, human"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics"], "DescriptorName": "Cell Differentiation"}, {"QualifierName": [], "DescriptorName": "Cell Line"}, {"QualifierName": ["metabolism", "cytology"], "DescriptorName": "Erythroid Cells"}, {"QualifierName": ["metabolism", "genetics"], "DescriptorName": "GATA1 Transcription Factor"}, {"QualifierName": ["metabolism", "genetics"], "DescriptorName": "GATA2 Transcription Factor"}, {"QualifierName": [], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": ["metabolism", "genetics"], "DescriptorName": "LIM Domain Proteins"}, {"QualifierName": ["metabolism", "cytology"], "DescriptorName": "Megakaryocytes"}, {"QualifierName": ["metabolism", "genetics"], "DescriptorName": "Proto-Oncogene Protein c-fli-1"}, {"QualifierName": ["metabolism", "genetics"], "DescriptorName": "Transcriptional Regulator ERG"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Orkin SH, Zon LI. Hematopoiesis: An evolving paradigm for stem cell biology. Cell. 2008;132:631\u2013644. doi: 10.1016/j.cell.2008.01.025.", "ArticleIdList": ["10.1016/j.cell.2008.01.025", "PMC2628169", "18295580"]}, {"Citation": "Teitell MA, Mikkola HK. Transcriptional activators, repressors, and epigenetic modifiers controlling hematopoietic stem cell development. Pediatr Res. 2006;59:33R\u201339R. doi: 10.1203/01.pdr.0000205155.26315.c7.", "ArticleIdList": ["10.1203/01.pdr.0000205155.26315.c7", "16549546"]}, {"Citation": "Wickrema A, Crispino JD. Erythroid and megakaryocytic transformation. Oncogene. 2007;26:6803\u20136815. doi: 10.1038/sj.onc.1210763.", "ArticleIdList": ["10.1038/sj.onc.1210763", "17934487"]}, {"Citation": "Tijssen MR, Cvejic A, Joshi A, Hannah RL, Ferreira R, Forrai A, Bellissimo DC, Oram SH, Smethurst PA, Wilson NK, et al. Genome-wide analysis of simultaneous GATA1/2, RUNX1, FLI1, and SCL binding in megakaryocytes identifies hematopoietic regulators. Dev Cell. 2011;20:597\u2013609. doi: 10.1016/j.devcel.2011.04.008.", "ArticleIdList": ["10.1016/j.devcel.2011.04.008", "PMC3145975", "21571218"]}, {"Citation": "Subramanian S, Thoms JAI, Huang Y, Cornejo-P\u00e1ramo P, Koch FC, Jacquelin S, Shen S, Song E, Joshi S, Brownlee C, et al. Genome-wide transcription factor binding maps reveal cell-specific changes in the regulatory architecture of human HSPC. Blood. 2023;142:1448\u20131462. doi: 10.1182/blood.2023021120.", "ArticleIdList": ["10.1182/blood.2023021120", "PMC10651876", "37595278"]}, {"Citation": "Beck D, Thoms JA, Perera D, Sch\u00fctte J, Unnikrishnan A, Knezevic K, Kinston SJ, Wilson NK, O'Brien TA, G\u00f6ttgens B, et al. Genome-wide analysis of transcriptional regulators in human HSPCs reveals a densely interconnected network of coding and noncoding genes. Blood. 2013;122:e12\u2013e22. doi: 10.1182/blood-2013-03-490425.", "ArticleIdList": ["10.1182/blood-2013-03-490425", "23974199"]}, {"Citation": "Diffner E, Beck D, Gudgin E, Thoms JA, Knezevic K, Pridans C, Foster S, Goode D, Lim WK, Boelen L, et al. Activity of a heptad of transcription factors is associated with stem cell programs and clinical outcome in acute myeloid leukemia. Blood. 2013;121:2289\u20132300. doi: 10.1182/blood-2012-07-446120.", "ArticleIdList": ["10.1182/blood-2012-07-446120", "23327922"]}, {"Citation": "Ben-David Y, Giddens EB, Bernstein A. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by friend murine leukemia virus. Proc Natl Acad Sci USA. 1990;87:1332\u20131336. doi: 10.1073/pnas.87.4.1332.", "ArticleIdList": ["10.1073/pnas.87.4.1332", "PMC53469", "2304901"]}, {"Citation": "Ben-David Y, Giddens EB, Letwin K, Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: Insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 1991;5:908\u2013918. doi: 10.1101/gad.5.6.908.", "ArticleIdList": ["10.1101/gad.5.6.908", "2044959"]}, {"Citation": "Pereira R, Quang CT, Lesault I, Dolznig H, Beug H, Ghysdael J. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts. Oncogene. 1999;18:1597\u20131608. doi: 10.1038/sj.onc.1202534.", "ArticleIdList": ["10.1038/sj.onc.1202534", "10102630"]}, {"Citation": "Tamir A, Howard J, Higgins RR, Li YJ, Berger L, Zacksenhaus E, Reis M, Ben-David Y. Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: Evidence for direct transcriptional repression of the Rb gene during differentiation. Mol Cell Biol. 1999;19:4452\u20134464. doi: 10.1128/MCB.19.6.4452.", "ArticleIdList": ["10.1128/MCB.19.6.4452", "PMC104404", "10330185"]}, {"Citation": "Athanasiou M, Mavrothalassitis G, Sun-Hoffman L, Blair DG. FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells. Leukemia. 2000;14:439\u2013445. doi: 10.1038/sj.leu.2401689.", "ArticleIdList": ["10.1038/sj.leu.2401689", "10720139"]}, {"Citation": "Starck J, Weiss-Gayet M, Gonnet C, Guyot B, Vicat JM, Morl\u00e9 F. Inducible Fli-1 gene deletion in adult mice modifies several myeloid lineage commitment decisions and accelerates proliferation arrest and terminal erythrocytic differentiation. Blood. 2010;116:4795\u20134805. doi: 10.1182/blood-2010-02-270405.", "ArticleIdList": ["10.1182/blood-2010-02-270405", "20733157"]}, {"Citation": "Liu T, Yao Y, Zhang G, Wang Y, Deng B, Song J, Li X, Han F, Xiao X, Yang J, et al. A screen for Fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis. Oncotarget. 2017;8:16728\u201316743. doi: 10.18632/oncotarget.14377.", "ArticleIdList": ["10.18632/oncotarget.14377", "PMC5369997", "28052010"]}, {"Citation": "Liu F, Walmsley M, Rodaway A, Patient R. Fli1 acts at the top of the transcriptional network driving blood and endothelial development. Curr Biol. 2008;18:1234\u20131240. doi: 10.1016/j.cub.2008.07.048.", "ArticleIdList": ["10.1016/j.cub.2008.07.048", "18718762"]}, {"Citation": "Ben-David Y, Gajendran B, Sample KM, Zacksenhaus E. Current insights into the role of Fli-1 in hematopoiesis and malignant transformation. Cell Mol Life Sci. 2022;79:163. doi: 10.1007/s00018-022-04160-1.", "ArticleIdList": ["10.1007/s00018-022-04160-1", "PMC11072361", "35412146"]}, {"Citation": "Love PE, Warzecha C, Li L. Ldb1 complexes: The new master regulators of erythroid gene transcription. Trends Genet. 2014;30:1\u20139. doi: 10.1016/j.tig.2013.10.001.", "ArticleIdList": ["10.1016/j.tig.2013.10.001", "PMC3882320", "24290192"]}, {"Citation": "Li L, Lee JY, Gross J, Song SH, Dean A, Love PE. A requirement for Lim domain binding protein 1 in erythropoiesis. J Exp Med. 2010;207:2543\u20132550. doi: 10.1084/jem.20100504.", "ArticleIdList": ["10.1084/jem.20100504", "PMC2989770", "21041453"]}, {"Citation": "Lee J, Krivega I, Dale RK, Dean A. The LDB1 complex Co-opts CTCF for erythroid lineage-specific long-range enhancer interactions. Cell Rep. 2017;19:2490\u20132502. doi: 10.1016/j.celrep.2017.05.072.", "ArticleIdList": ["10.1016/j.celrep.2017.05.072", "PMC5564295", "28636938"]}, {"Citation": "Soler E, Andrieu-Soler C, de Boer E, Bryne JC, Thongjuea S, Stadhouders R, Palstra RJ, Stevens M, Kockx C, van Ijcken W, et al. The genome-wide dynamics of the binding of Ldb1 complexes during erythroid differentiation. Genes Dev. 2010;24:277\u2013289. doi: 10.1101/gad.551810.", "ArticleIdList": ["10.1101/gad.551810", "PMC2811829", "20123907"]}, {"Citation": "Krivega I, Dale RK, Dean A. Role of LDB1 in the transition from chromatin looping to transcription activation. Genes Dev. 2014;28:1278\u20131290. doi: 10.1101/gad.239749.114.", "ArticleIdList": ["10.1101/gad.239749.114", "PMC4066399", "24874989"]}, {"Citation": "Deng W, Lee J, Wang H, Miller J, Reik A, Gregory PD, Dean A, Blobel GA. Controlling long-range genomic interactions at a native locus by targeted tethering of a looping factor. Cell. 2012;149:1233\u20131244. doi: 10.1016/j.cell.2012.03.051.", "ArticleIdList": ["10.1016/j.cell.2012.03.051", "PMC3372860", "22682246"]}, {"Citation": "Stadhouders R, Cico A, Stephen T, Thongjuea S, Kolovos P, Baymaz HI, Yu X, Demmers J, Bezstarosti K, Maas A, et al. Control of developmentally primed erythroid genes by combinatorial co-repressor actions. Nat Commun. 2015;6:8893. doi: 10.1038/ncomms9893.", "ArticleIdList": ["10.1038/ncomms9893", "PMC4673834", "26593974"]}, {"Citation": "Giraud G, Kolovos P, Boltsis I, van Staalduinen J, Guyot B, Weiss-Gayet M, IJcken WV, Morl\u00e9 F, Grosveld F. Interplay between FLI-1 and the LDB1 complex in murine erythroleukemia cells and during megakaryopoiesis. iScience. 2021;24:102210. doi: 10.1016/j.isci.2021.102210.", "ArticleIdList": ["10.1016/j.isci.2021.102210", "PMC7940982", "33733070"]}, {"Citation": "Eisbacher M, Holmes ML, Newton A, Hogg PJ, Khachigian LM, Crossley M, Chong BH. Protein-protein interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocyte-specific genes through cooperative DNA binding. Mol Cell Biol. 2003;23:3427\u20133441. doi: 10.1128/MCB.23.10.3427-3441.2003.", "ArticleIdList": ["10.1128/MCB.23.10.3427-3441.2003", "PMC154245", "12724402"]}, {"Citation": "Li YJ, Zhao X, Vecchiarelli-Federico LM, Li Y, Datti A, Cheng Y, Ben-David Y. Drug-mediated inhibition of Fli-1 for the treatment of leukemia. Blood Cancer J. 2012;2:e54. doi: 10.1038/bcj.2011.52.", "ArticleIdList": ["10.1038/bcj.2011.52", "PMC3270256", "22829238"]}, {"Citation": "Wang C, Song J, Liu W, Yao Y, Kapranov P, Sample KM, Gajendran B, Zacksenhaus E, Hao X, Ben-David Y. FLI1 promotes protein translation via the transcriptional regulation of MKNK1 expression. Int J Oncol. 2020;56:430\u2013438.", "ArticleIdList": ["PMC6959374", "31894299"]}, {"Citation": "Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods. 2001;25:402\u2013408. doi: 10.1006/meth.2001.1262.", "ArticleIdList": ["10.1006/meth.2001.1262", "11846609"]}, {"Citation": "Wang C, Sample KM, Gajendran B, Kapranov P, Liu W, Hu A, Zacksenhaus E, Li Y, Hao X, Ben-David Y. FLI1 induces megakaryopoiesis gene expression through WAS/WIP-dependent and independent mechanisms; Implications for wiskott-aldrich syndrome. Front Immunol. 2021;12:607836. doi: 10.3389/fimmu.2021.607836.", "ArticleIdList": ["10.3389/fimmu.2021.607836", "PMC7953068", "33717090"]}, {"Citation": "Chen C, Chen H, Zhang Y, Thomas HR, Frank MH, He Y, Xia R. TBtools: An integrative toolkit developed for interactive analyses of big biological data. Mol Plant. 2020;13:1194\u20131202. doi: 10.1016/j.molp.2020.06.009.", "ArticleIdList": ["10.1016/j.molp.2020.06.009", "32585190"]}, {"Citation": "Song J, Yuan C, Yang J, Liu T, Yao Y, Xiao X, Gajendran B, Xu D, Li YJ, Wang C, et al. Novel flavagline-like compounds with potent Fli-1 inhibitory activity suppress diverse types of leukemia. FEBS J. 2018;285:4631\u20134645. doi: 10.1111/febs.14690.", "ArticleIdList": ["10.1111/febs.14690", "30387554"]}, {"Citation": "Barbeau B, Barat C, Bergeron D, Rassart E. The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1. Oncogene. 1999;18:5535\u20135545. doi: 10.1038/sj.onc.1202913.", "ArticleIdList": ["10.1038/sj.onc.1202913", "10523830"]}, {"Citation": "An X, Chen L. Flow cytometry (FCM) analysis and fluorescence-activated cell sorting (FACS) of erythroid cells. Methods Mol Biol. 2018;1698:153\u2013174. doi: 10.1007/978-1-4939-7428-3_9.", "ArticleIdList": ["10.1007/978-1-4939-7428-3_9", "29076089"]}, {"Citation": "Nakahata T, Okumura N. Cell surface antigen expression in human erythroid progenitors: Erythroid and megakaryocytic markers. Leuk Lymphoma. 1994;13:401\u2013409. doi: 10.3109/10428199409049629.", "ArticleIdList": ["10.3109/10428199409049629", "8069185"]}, {"Citation": "ENCODE Project Consortium, corp-author. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489:57\u201374. doi: 10.1038/nature11247.", "ArticleIdList": ["10.1038/nature11247", "PMC3439153", "22955616"]}, {"Citation": "Zhang P, Basu P, Redmond LC, Morris PE, Rupon JW, Ginder GD, Lloyd JA. A functional screen for Kr\u00fcppel-like factors that regulate the human gamma-globin gene through the CACCC promoter element. Blood Cells Mol Dis. 2005;35:227\u2013235. doi: 10.1016/j.bcmd.2005.04.009.", "ArticleIdList": ["10.1016/j.bcmd.2005.04.009", "16023392"]}, {"Citation": "Starck J, Cohet N, Gonnet C, Sarrazin S, Doubeikovskaia Z, Doubeikovski A, Verger A, Duterque-Coquillaud M, Morle F. Functional cross-antagonism between transcription factors FLI-1 and EKLF. Mol Cell Biol. 2003;23:1390\u20131402. doi: 10.1128/MCB.23.4.1390-1402.2003.", "ArticleIdList": ["10.1128/MCB.23.4.1390-1402.2003", "PMC141137", "12556498"]}, {"Citation": "Neuwirtova R, Fuchs O, Holicka M, Vostry M, Kostecka A, Hajkova H, Jonasova A, Cermak J, Cmejla R, Pospisilova D, et al. Transcription factors Fli1 and EKLF in the differentiation of megakaryocytic and erythroid progenitor in 5q-syndrome and in Diamond-Blackfan anemia. Ann Hematol. 2013;92:11\u201318. doi: 10.1007/s00277-012-1568-1.", "ArticleIdList": ["10.1007/s00277-012-1568-1", "22965552"]}, {"Citation": "Merika M, Orkin SH. Functional synergy and physical interactions of the erythroid transcription factor GATA-1 with the Kr\u00fcppel family proteins Sp1 and EKLF. Mol Cell Biol. 1995;15:2437\u20132447. doi: 10.1128/MCB.15.5.2437.", "ArticleIdList": ["10.1128/MCB.15.5.2437", "PMC230473", "7739528"]}, {"Citation": "Yamaoka A, Suzuki M, Katayama S, Orihara D, Engel JD, Yamamoto M. EVI1 and GATA2 misexpression induced by inv(3)(q21q26) contribute to megakaryocyte-lineage skewing and leukemogenesis. Blood Adv. 2020;4:1722\u20131736. doi: 10.1182/bloodadvances.2019000978.", "ArticleIdList": ["10.1182/bloodadvances.2019000978", "PMC7189294", "32330245"]}, {"Citation": "Johnson KD, Conn DJ, Shishkova E, Katsumura KR, Liu P, Shen S, Ranheim EA, Kraus SG, Wang W, Calvo KR, et al. Constructing and deconstructing GATA2-regulated cell fate programs to establish developmental trajectories. J Exp Med. 2020;217:e20191526. doi: 10.1084/jem.20191526.", "ArticleIdList": ["10.1084/jem.20191526", "PMC7596813", "32736380"]}, {"Citation": "Yi G, Mandoli A, Jussen L, Tijchon E, van Bergen MGJM, Cordonnier G, Hansen M, Kim B, Nguyen LN, Jansen PWTC, et al. CBF\u03b2-MYH11 interferes with megakaryocyte differentiation via modulating a gene program that includes GATA2 and KLF1. Blood Cancer J. 2019;9:33. doi: 10.1038/s41408-019-0194-8.", "ArticleIdList": ["10.1038/s41408-019-0194-8", "PMC6408575", "30850577"]}, {"Citation": "Ikonomi P, Rivera CE, Riordan M, Washington G, Schechter AN, Noguchi CT. Overexpression of GATA-2 inhibits erythroid and promotes megakaryocyte differentiation. Exp Hematol. 2000;28:1423\u20131431. doi: 10.1016/S0301-472X(00)00553-1.", "ArticleIdList": ["10.1016/S0301-472X(00)00553-1", "11146164"]}, {"Citation": "Li Y, Ke Q, Shao Y, Zhu G, Li Y, Geng N, Jin F, Li F. GATA1 induces epithelial-mesenchymal transition in breast cancer cells through PAK5 oncogenic signaling. Oncotarget. 2015;6:4345\u20134356. doi: 10.18632/oncotarget.2999.", "ArticleIdList": ["10.18632/oncotarget.2999", "PMC4414194", "25726523"]}, {"Citation": "Yu J, Liu M, Liu H, Zhou L. GATA1 promotes colorectal cancer cell proliferation, migration and invasion via activating AKT signaling pathway. Mol Cell Biochem. 2019;457:191\u2013199. doi: 10.1007/s11010-019-03523-w.", "ArticleIdList": ["10.1007/s11010-019-03523-w", "31069596"]}, {"Citation": "Carmichael CL, Metcalf D, Henley KJ, Kruse EA, Di Rago L, Mifsud S, Alexander WS, Kile BT. Hematopoietic overexpression of the transcription factor Erg induces lymphoid and erythro-megakaryocytic leukemia. Proc Natl Acad Sci USA. 2012;109:15437\u201315442. doi: 10.1073/pnas.1213454109.", "ArticleIdList": ["10.1073/pnas.1213454109", "PMC3458381", "22936051"]}, {"Citation": "Mukhopadhyay M, Teufel A, Yamashita T, Agulnick AD, Chen L, Downs KM, Schindler A, Grinberg A, Huang SP, Dorward D, Westphal H. Functional ablation of the mouse Ldb1 gene results in severe patterning defects during gastrulation. Development. 2003;130:495\u2013505. doi: 10.1242/dev.00225.", "ArticleIdList": ["10.1242/dev.00225", "12490556"]}, {"Citation": "Song SH, Kim A, Ragoczy T, Bender MA, Groudine M, Dean A. Multiple functions of Ldb1 required for beta-globin activation during erythroid differentiation. Blood. 2010;116:2356\u20132364. doi: 10.1182/blood-2010-03-272252.", "ArticleIdList": ["10.1182/blood-2010-03-272252", "PMC2953839", "20570862"]}, {"Citation": "Visvader JE, Mao X, Fujiwara Y, Hahm K, Orkin SH. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation. Proc Natl Acad Sci USA. 1997;94:13707\u201313712. doi: 10.1073/pnas.94.25.13707.", "ArticleIdList": ["10.1073/pnas.94.25.13707", "PMC28370", "9391090"]}, {"Citation": "Liu T, Xia L, Yao Y, Yan C, Fan Y, Gajendran B, Yang J, Li YJ, Chen J, Filmus J, et al. Identification of diterpenoid compounds that interfere with Fli-1 DNA binding to suppress leukemogenesis. Cell Death Dis. 2019;10:117. doi: 10.1038/s41419-019-1363-1.", "ArticleIdList": ["10.1038/s41419-019-1363-1", "PMC6370842", "30741932"]}]}], "History": [{"Year": "2023", "Month": "12", "Day": "8"}, {"Year": "2024", "Month": "3", "Day": "21"}, {"Year": "2024", "Month": "5", "Day": "2", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "5", "Day": "2", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "5", "Day": "2", "Hour": "5", "Minute": "23"}, {"Year": "2024", "Month": "4", "Day": "26"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38695236", "PMC11082641", "10.3892/mmr.2024.13231", "107"]}}]}